Back to Agenda
Session 15: Common Technical Document - Module 1
Session Chair(s)
Albert S. Yehaskel, MBA
President and CEO
Refuah Global Pharmaceutical Development, Inc., United States
- Organization and Review of Module 1
Have an account?
Already a DIA Member? Sign in. Not a member? Join.
Sign in
Not a Member?
DIA Global Center
Oct 15, 2018 8:15 AM - Oct 16, 2018 3:30 PM
21 Dupont Circle NW, Suite 300, Washington, DC 20036
Back to Agenda
President and CEO
Refuah Global Pharmaceutical Development, Inc., United States
Have an account?